Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL-class fusion

Anthony V. Moorman, Claire Schwab, Emily Winterman, Jerry Hancock, Anna Castleton, Michelle Cummins, Brenda Gibson, Nick Goulden, Pam Kearns, Beki James, Amy A. Kirkwood, Donna Lancaster, Mabrouk Madi, Andrew McMillan, Jayashree Motwani, Alice Norton, Aengus O’Marcaigh, Katharine Patrick, Neha Bhatnagar, Amrana QureshiDeborah Richardson, Simone Stokley, Gordon Taylor, Frederik W. van Delft, John Moppett, Christine J. Harrison, Sujith Samarasinghe, Ajay Vora

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL-class fusion'. Together they form a unique fingerprint.

Medicine & Life Sciences